Cargando…

Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers

INTRODUCTION: DFNA9 is characterized by adult-onset hearing loss and evolution toward bilateral vestibulopathy (BVP). The genotype-phenotype correlation studies were conducted 15 years ago. However, their conclusions were mainly based on symptomatic carriers and the vestibular data exclusively deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: JanssensdeVarebeke, Sebastien P. F., Moyaert, Julie, Fransen, Erik, Bulen, Britt, Neesen, Celine, Devroye, Katrien, van de Berg, Raymond, Pennings, Ronald J. E., Topsakal, Vedat, Vanderveken, Olivier, Van Camp, Guy, Van Rompaey, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542091/
https://www.ncbi.nlm.nih.gov/pubmed/34369417
http://dx.doi.org/10.1097/AUD.0000000000001070
_version_ 1784589367255236608
author JanssensdeVarebeke, Sebastien P. F.
Moyaert, Julie
Fransen, Erik
Bulen, Britt
Neesen, Celine
Devroye, Katrien
van de Berg, Raymond
Pennings, Ronald J. E.
Topsakal, Vedat
Vanderveken, Olivier
Van Camp, Guy
Van Rompaey, Vincent
author_facet JanssensdeVarebeke, Sebastien P. F.
Moyaert, Julie
Fransen, Erik
Bulen, Britt
Neesen, Celine
Devroye, Katrien
van de Berg, Raymond
Pennings, Ronald J. E.
Topsakal, Vedat
Vanderveken, Olivier
Van Camp, Guy
Van Rompaey, Vincent
author_sort JanssensdeVarebeke, Sebastien P. F.
collection PubMed
description INTRODUCTION: DFNA9 is characterized by adult-onset hearing loss and evolution toward bilateral vestibulopathy (BVP). The genotype-phenotype correlation studies were conducted 15 years ago. However, their conclusions were mainly based on symptomatic carriers and the vestibular data exclusively derived from the horizontal (lateral) semicircular canal (SCC). The last decade was marked by the emergence of new clinical diagnostic tools, such as the video head impulse test (vHIT) and vestibular-evoked myogenic evoked potentials (VEMPs), expanding our evaluation to all six SCCs and the otolith organs (saccule and utricule). AIM: The aim of this study was to comprehensively evaluate vestibular function in the largest series presymptomatic as well as symptomatic p.P51S variant carriers, to determine which labyrinthine part shows the first signs of deterioration and which SCC function declines at first and to determine the age at which p.P51S variant carriers develop caloric areflexia on VNG and vHIT vestibulo-ocular reflex (VOR)-gain dysfunction as defined by the Barany Society criteria for BVP. MATERIAL AND METHODS: One hundred eleven p.P51S variant carriers were included. The following vestibular function tests were applied in two different centers: ENG/VNG, vHIT, and VEMPs. The following parameters were analyzed: age (years), hearing loss (pure-tone average of 0.5–4 kHz [PTA(0.5–4), dB HL]), sum of maximal peak slow-phase eye velocity obtained with bi-thermal (30°C and 44°C, water irrigation; 25°C and 44°C, air irrigation) caloric test (°/s), vHIT VOR-gain on LSCC, superior SCC and posterior SCC, C-VEMP both numerical (threshold, dB nHL) and categorical (present or absent), and O-VEMP as categorical (present or absent). The age of onset of vestibular dysfunction was determined both with categorical (onset in decades using Box & Whisker plots) and numeric approach (onset in years using regression analysis). The same method was applied for determining the age at which vestibular function declined beyond the limits of BVP, as defined by the Barany Society. RESULTS: With the categorical approach, otolith function was declining first (3rd decade), followed by caloric response (5th decade) and vHIT VOR-gains (5th–6th decade). Estimated age of onset showed that the deterioration began with C-VEMP activity (31 years), followed by caloric responses (water irrigation) (35 years) and ended with vHIT VOR-gains (48–57 years). Hearing deterioration started earlier than vestibular deterioration in female carriers, which is different from earlier reports. BVP was predicted at about 53 years of age on average with VNG caloric gain (water irrigation) and between 47 and 57 years of age for the three SCCs. Loss of C-VEMP response was estimated at about 46 years of age. CONCLUSION: Former hypothesis of vestibular decline preceding hearing deterioration by 9 years was confirmed by the numeric approach, but this was less obvious with the categorical approach. Wide confidence intervals of the regression models may explain deviation of the fits from true relationship. There is a typical vestibular deterioration hierarchy in p.P51S variant carriers. To further refine the present findings, a prospective longitudinal study of the auditory and vestibular phenotype may help to get even better insights in this matter.
format Online
Article
Text
id pubmed-8542091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85420912021-10-27 Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers JanssensdeVarebeke, Sebastien P. F. Moyaert, Julie Fransen, Erik Bulen, Britt Neesen, Celine Devroye, Katrien van de Berg, Raymond Pennings, Ronald J. E. Topsakal, Vedat Vanderveken, Olivier Van Camp, Guy Van Rompaey, Vincent Ear Hear Clinical Trials INTRODUCTION: DFNA9 is characterized by adult-onset hearing loss and evolution toward bilateral vestibulopathy (BVP). The genotype-phenotype correlation studies were conducted 15 years ago. However, their conclusions were mainly based on symptomatic carriers and the vestibular data exclusively derived from the horizontal (lateral) semicircular canal (SCC). The last decade was marked by the emergence of new clinical diagnostic tools, such as the video head impulse test (vHIT) and vestibular-evoked myogenic evoked potentials (VEMPs), expanding our evaluation to all six SCCs and the otolith organs (saccule and utricule). AIM: The aim of this study was to comprehensively evaluate vestibular function in the largest series presymptomatic as well as symptomatic p.P51S variant carriers, to determine which labyrinthine part shows the first signs of deterioration and which SCC function declines at first and to determine the age at which p.P51S variant carriers develop caloric areflexia on VNG and vHIT vestibulo-ocular reflex (VOR)-gain dysfunction as defined by the Barany Society criteria for BVP. MATERIAL AND METHODS: One hundred eleven p.P51S variant carriers were included. The following vestibular function tests were applied in two different centers: ENG/VNG, vHIT, and VEMPs. The following parameters were analyzed: age (years), hearing loss (pure-tone average of 0.5–4 kHz [PTA(0.5–4), dB HL]), sum of maximal peak slow-phase eye velocity obtained with bi-thermal (30°C and 44°C, water irrigation; 25°C and 44°C, air irrigation) caloric test (°/s), vHIT VOR-gain on LSCC, superior SCC and posterior SCC, C-VEMP both numerical (threshold, dB nHL) and categorical (present or absent), and O-VEMP as categorical (present or absent). The age of onset of vestibular dysfunction was determined both with categorical (onset in decades using Box & Whisker plots) and numeric approach (onset in years using regression analysis). The same method was applied for determining the age at which vestibular function declined beyond the limits of BVP, as defined by the Barany Society. RESULTS: With the categorical approach, otolith function was declining first (3rd decade), followed by caloric response (5th decade) and vHIT VOR-gains (5th–6th decade). Estimated age of onset showed that the deterioration began with C-VEMP activity (31 years), followed by caloric responses (water irrigation) (35 years) and ended with vHIT VOR-gains (48–57 years). Hearing deterioration started earlier than vestibular deterioration in female carriers, which is different from earlier reports. BVP was predicted at about 53 years of age on average with VNG caloric gain (water irrigation) and between 47 and 57 years of age for the three SCCs. Loss of C-VEMP response was estimated at about 46 years of age. CONCLUSION: Former hypothesis of vestibular decline preceding hearing deterioration by 9 years was confirmed by the numeric approach, but this was less obvious with the categorical approach. Wide confidence intervals of the regression models may explain deviation of the fits from true relationship. There is a typical vestibular deterioration hierarchy in p.P51S variant carriers. To further refine the present findings, a prospective longitudinal study of the auditory and vestibular phenotype may help to get even better insights in this matter. Lippincott Williams & Wilkins 2021-10-22 /pmc/articles/PMC8542091/ /pubmed/34369417 http://dx.doi.org/10.1097/AUD.0000000000001070 Text en Copyright © 2021 The Authors. Ear & Hearing is published on behalf of the American Auditory Society, by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical Trials
JanssensdeVarebeke, Sebastien P. F.
Moyaert, Julie
Fransen, Erik
Bulen, Britt
Neesen, Celine
Devroye, Katrien
van de Berg, Raymond
Pennings, Ronald J. E.
Topsakal, Vedat
Vanderveken, Olivier
Van Camp, Guy
Van Rompaey, Vincent
Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title_full Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title_fullStr Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title_full_unstemmed Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title_short Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers
title_sort genotype-phenotype correlation study in a large series of patients carrying the p.pro51ser (p.p51s) variant in coch (dfna9) part ii: a prospective cross-sectional study of the vestibular phenotype in 111 carriers
topic Clinical Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542091/
https://www.ncbi.nlm.nih.gov/pubmed/34369417
http://dx.doi.org/10.1097/AUD.0000000000001070
work_keys_str_mv AT janssensdevarebekesebastienpf genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT moyaertjulie genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT fransenerik genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT bulenbritt genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT neesenceline genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT devroyekatrien genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT vandebergraymond genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT penningsronaldje genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT topsakalvedat genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT vandervekenolivier genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT vancampguy genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers
AT vanrompaeyvincent genotypephenotypecorrelationstudyinalargeseriesofpatientscarryingtheppro51serpp51svariantincochdfna9partiiaprospectivecrosssectionalstudyofthevestibularphenotypein111carriers